Identification of modulators of neurotransmitter activity of xanthurenic acid
CA 2451092 A1 · Owner: Maitre, Michel · Inventors: Gobaille, Serge; Maitre, Michel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to methods and compositions for the selection and development of novel pharmacological agents or novel medicaments having properties or action mechanisms which are original. The invention specifically describes the characterization and identification of the functional role of several constitutive elements of the central nervous system playing a role in the metabolism or transport of xanthurenic acid (XA) or involved in receiving and/or transducing the signal mediated by said substance. Said targets are new tools for the definition and selection of novel synthetic chemical substances interfering with said targets and modulating the functions of XA in order to benefit …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 4, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.